A landmark report led by Chinese experts and published in The Lancet on World Hepatitis Day offers a new global roadmap to address the growing burden of liver cancer. This marks the first time in over 200 years that The Lancet has published global health research led by Chinese scientists. The report highlights that liver cancer, which causes around 870,000 new cases and 760,000 deaths each year, is increasingly linked not only to hepatitis B and C but also to rising cases associated with metabolic liver disease and alcohol consumption. It estimates that about 60 percent of liver cancer cases can be prevented through measures such as hepatitis B vaccination, antiviral treatments, lifestyle changes, and early screening.
The report proposes a comprehensive strategy focusing on expanding vaccination and treatment, increasing public awareness about unhealthy diets and alcohol, integrating liver fibrosis screening for high-risk groups using accessible testing methods, and improving treatment access while addressing regional disparities and including early palliative care. Without effective interventions, liver cancer cases and deaths could nearly double by 2050. However, the report suggests that achieving a sustained 2 percent annual reduction in incidence rates could prevent millions of new cases and deaths over the next 25 years.
Credit: CGTN